Literature DB >> 15505035

Identification of target genes regulated by FOXC1 using nickel agarose-based chromatin enrichment.

Yahya Tamimi1, Matthew Lines, Miguel Coca-Prados, Michael A Walter.   

Abstract

PURPOSE: To overcome the problem of antibody availability, often encountered during chromatin immunoprecipitation (ChIP) assays, nickel agarose-based chromatin enrichment (NACE) was developed. Based on the affinity of (His)-6-tagged proteins for the nickel ion, this modified form of ChIP allows the isolation of chromatin in the absence of specific antibodies.
METHODS: Nonpigmented ciliary epithelium cells were transfected with (His)-6-tagged FOXC1. FOXC1-enriched chromatin complexes were isolated by using the tight electrostatic interaction between histidine residues of the recombinant FOXC1 protein and nickel. One hundred fifty NACE-enriched clones were sequenced and subjected to in silico and biochemical analyses.
RESULTS: Twenty-six clones were detected near known genes: Eight were near predicted but uncharacterized genes, eight were within areas where neither known nor predicted genes have yet been mapped, four were chimeric, and the rest were either repetitive (n=81) or poor-quality (n=23) sequences. Twenty of the 26 known genes were expressed in the eye. Five of the NACE-enriched clones (BMP2K, DACH, FVT-1, SIX-1, and PGE-2 receptor), as well as nine clones selected from the literature, were validated by PCR amplification in two independent lots of NACE-enriched chromatin. All five NACE-selected genes were detected in two independent assays, as well as four (BMP7, SMAD2, TGF-B1, and WNT6) of the nine genes selected from the literature, consistent with these genes' being regulated by FOXC1.
CONCLUSIONS: NACE is a useful technique allowing specific chromatin enrichment in cases where antibodies are unavailable. Specific recovery of PTGER, DACH1, WNT6, and FVT-1 implicates FOXC1 in a variety of cellular events including modulation of intraocular pressure, cell cycle, ocular development, and oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505035     DOI: 10.1167/iovs.04-0628

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2.

Authors:  Theodora E Danciu; Sergey Chupreta; Osvaldo Cruz; Jennifer E Fox; Malcolm Whitman; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

2.  The extracytoplasmic function sigma factor EcfO protects Bacteroides fragilis against oxidative stress.

Authors:  Ivan C Ndamukong; Jason Gee; C Jeffrey Smith
Journal:  J Bacteriol       Date:  2012-10-26       Impact factor: 3.490

3.  Structure and function of the Escherichia coli protein YmgB: a protein critical for biofilm formation and acid-resistance.

Authors:  Jintae Lee; Rebecca Page; Rodolfo García-Contreras; Jeanne-Marie Palermino; Xue-Song Zhang; Ojus Doshi; Thomas K Wood; Wolfgang Peti
Journal:  J Mol Biol       Date:  2007-08-02       Impact factor: 5.469

4.  WNT5A is regulated by PAX2 and may be involved in blastemal predominant Wilms tumorigenesis.

Authors:  Yahya Tamimi; Usukuma Ekuere; Nicholas Laughton; Paul Grundy
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

5.  Strain-Dependent Anterior Segment Dysgenesis and Progression to Glaucoma in Col4a1 Mutant Mice.

Authors:  Mao Mao; Richard S Smith; Marcel V Alavi; Jeffrey K Marchant; Mihai Cosma; Richard T Libby; Simon W M John; Douglas B Gould
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

6.  Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.

Authors:  Simone Buraschi; Thomas Neill; Rick T Owens; Leonardo A Iniguez; George Purkins; Rajanikanth Vadigepalli; Barry Evans; Liliana Schaefer; Stephen C Peiper; Zi-Xuan Wang; Renato V Iozzo
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

7.  Compound developmental eye disorders following inactivation of TGFbeta signaling in neural-crest stem cells.

Authors:  Lars M Ittner; Heiko Wurdak; Kerstin Schwerdtfeger; Thomas Kunz; Fabian Ille; Per Leveen; Tord A Hjalt; Ueli Suter; Stefan Karlsson; Farhad Hafezi; Walter Born; Lukas Sommer
Journal:  J Biol       Date:  2005-12-14

8.  Identification of the first intragenic deletion of the PITX2 gene causing an Axenfeld-Rieger Syndrome: case report.

Authors:  Guillaume de la Houssaye; Ivan Bieche; Olivier Roche; Véronique Vieira; Ingrid Laurendeau; Laurence Arbogast; Hatem Zeghidi; Philippe Rapp; Philippe Halimi; Michel Vidaud; Jean-Louis Dufier; Maurice Menasche; Marc Abitbol
Journal:  BMC Med Genet       Date:  2006-11-29       Impact factor: 2.103

9.  Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.

Authors:  Caroline Baynes; Catherine S Healey; Karen A Pooley; Serena Scollen; Robert N Luben; Deborah J Thompson; Paul D P Pharoah; Douglas F Easton; Bruce A J Ponder; Alison M Dunning
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

10.  Protein translation and cell death: the role of rare tRNAs in biofilm formation and in activating dormant phage killer genes.

Authors:  Rodolfo García-Contreras; Xue-Song Zhang; Younghoon Kim; Thomas K Wood
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.